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↑What is “already known” in this topic: 
In Iran, about 51 scorpion species have been reported, among 
which 11 species are medically important. There is still no 
grading system for the severity of Iranian scorpion enven-
omation and no clear treatment guidelines for emergency phy-
sicians. 
→What this article adds: 
Hottentotta jayakari species should be regarded among the 
medically important scorpions of Iran. For the first time, a 
clinical severity grading for Iranian scorpion envenomation 
was presented.  
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Abstract 
    Background: Scorpionism is a public health problem in some provinces in Iran. The present study aimed to assess the clinical mani-
festations of scorpion envenomation in Shiraz and determine a clinical severity grading for Iranian scorpion envenomation in order to 
suggest a treatment guideline for emergency physicians.  
   Methods: In this analytic retrospective study, all medical charts of patients with scorpion sting admitted in the adult medical toxicol-
ogy center in Shiraz during July 2012 to July 2016 were assessed. Data regarding the patient's age, gender, sting site, month of enven-
omation, time of sting, clinical manifestations, vital signs, presence of blood or hemoglobin in urine analysis, duration of admission, 
color of scorpion, received treatments, and administration of scorpion antivenin were recorded.  
   Results: The scorpions in Shiraz and its suburban area were classified into two groups: yellow scorpions (Mesobuthus eupeus, Mes-
obuthus caucasicus, and Compsobuthus matthiesseni) and Hottentotta scorpions (Hottentotta jayakari and Hottentotta zagrosensis). A 
total of 126 cases of scorpion stings were assessed. About 59% (n=74) were males. The patients aged 8-63 years (mean age, 33.8±11.5 
years). About 38.4% (n=48) of the stings occurred during summer. More than 40% of patients (n=51) referred to the emergency de-
partment (ED) at night. Localized pain was the most frequent presenting complaint (76.2%). The most frequent general symptom was 
nausea (6.3%). The most prevalent envenomation site was the lower extremities followed by upper extremities (43.5% and 41.9%, 
respectively). Based on the clinical severity grading for Iranian scorpion envenomation, 65, 43, and 18 patients (51.6%, 34.1%, and 
14.3%) were classified in the grades I, II, and III, respectively. Eighty-one (73%) patients stayed in the ED from 1 to 6 hours, and 30 
(27%) patients stayed for >6 hours for observation. Severe localized pain was more prevalent in stings with Hottentotta scorpions than 
yellow scorpions (P=0.01). The season of envenomation with Hottentotta scorpions was summer in all cases, but envenomation with 
yellow scorpions was seen throughout the year. All patients received symptomatic treatment, and five were given scorpion antivenin. 
No death was reported.  
   Conclusion: Hottentotta jayakari is recommended to be listed among the medically important scorpions in Iran. Moreover, scorpi-
on-stung patients in geographical regions where Hemiscorpius lepturus and Androctonus crassicauda are not prevalent may be treated 
in outpatient departments. The presented grading system can be used for treating patients with scorpion envenomation. 
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Introduction 
Scorpions have been living on earth for more than 400 
years (1). So far, about 2000 scorpion species have been 
identified, 25 of which have medical significance (2, 3). 
Their venom differs among different species and consists 
of proteins and other substances (4). Annually, about half 
a million people are stung by scorpions worldwide with a 
mortality rate of 3250 individuals (5, 6). Scorpion stings 
are one of the most important environmental health haz-
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Fig. 1. Mesobuthus eupeus (original picture) 
 
ards in Iran. Although, more than fifty thousands of scor-
pion stings are reported annually, around 75% of fatal 
cases are reported from Khuzestan, Sistan-Baluchestan, 
Kerman and Hormozgan provinces (7-9).  
The Hemiscorpius lepturus and Androctonus crassicau-
da species are responsible for most fatal envenomation 
cases in Iran (9-12). The clinical manifestations of scorpi-
on envenomation can be a challenge for emergency physi-
cians since they are diverse, ranging from mild burning 
sensations at the sting site to critical fatal conditions (13).  
In Iran, about 51 scorpion species have been reported, 
among which 11 species are medically important (9, 14). 
The characteristics of these medically important scorpions 
and their clinical envenomation manifestations are provid-
ed in Table 1 (9-12, 14-33). Previous studies have report-
ed the clinical manifestations of scorpion stings in prov-
inces with high rates of scorpionism (7, 31-89). However, 
there is still no grading system for the severity of Iranian 
scorpion envenomation and no clear treatment guidelines 
for emergency physicians. Moreover, there is only one 
study on scorpion envenomation in Shiraz, reporting pa-
tients with scorpion envenomation to a tertiary hospital 
from southern Iran (90).  
The current study aimed to assess the clinical manifesta-
tions of scorpion envenomation in Shiraz and to determine 
a grading system regarding its severity via reviewing its 
clinical manifestations in Iran to provide a treatment 
guideline for emergency physicians.  
 
Methods 
Shiraz (N 52°32′E′37°29), the capital of Fars province, 
is the sixth most populated city in Iran situated in the 
southwest of the country and has a mild climate. Its popu-
lation was about 1,500,000 in the 2011 census (91). In 
July 2012, the Division of Medical Toxicology was estab-
lished in the Emergency Room of Hazrat Ali-Asghar (p) 
Hospital, as the only adult medical toxicology center in 
Shiraz. Until then, there was no information on the most 
common scorpion species and clinical manifestations of 
their stings in this geographical region. Hence, scorpions, 
brought by afflicted patients, were kept in alcohol 70% 
and sent to the laboratory of the Department of Environ-
mental Health of Kashan University of Medical Sciences. 
These scorpions were identified based on the diagnostic 
keys for Iranian scorpions (92-94). In this analytic retro-
spective study, all medical charts of patients with scorpion 
sting admitted during July 2012 to July 2016 were as-
sessed. Data regarding the patient's age, gender, site of 
sting, month of envenomation, time of sting, clinical man-
ifestations, vital signs, presence of blood or hemoglobin in 
urine analysis (U/A), duration of admission, color of scor-
pion, received treatments, and administration of scorpion 
antivenin were extracted and recorded. If the color of the 
scorpion was not in the records, the patients or their fami-
lies were called. Stings occurring in regions other than 
Shiraz and its suburban area were excluded from the 
study. Also, patients with underlying cardiovascular and 
renal diseases and those who were receiving anticoagu-
lants were excluded. Scorpions of the genus Hottentotta 
differ in terms of size and color with other solid yellow 
scorpions (94). In fact, stings with these great size scorpi-
ons with different coloration are more intimidating. More-
over, as they belong to a relatively large species of scorpi-
ons, severe clinical symptoms would be expected on their 
stings, depends upon the large amount of the venom in-
jected. Therefore, the scorpion stings were divided into 
stings from Hottentotta and yellow scorpions. A classifi-
cation was developed on the basis of the reported clinical 
manifestations of scorpion-stung patients from Iran (9-12, 
14-33) and was utilized to grade the clinical severity of 
scorpion envenomation for the stung patients. 
Data were analyzed by using SPSS software, version 
22.0 using Mann-Whitney U, Fisher's exact, Pearson's 
Chi-square, and student's t-test. A p-value of less than 
0.05 was considered statistically significant.  
 
Ethical considerations  
The study was approved on May 23, 2016 by the Com-
mittee of Ethics in Research, Medical School, Shiraz Uni-
versity of Medical Sciences and registered as IR.SUMS. 
MED.REC.1395.S98.      
 
Results 
A total of 28 scorpion samples of the patients were col-
lected. After identification at the laboratory, the scorpions 
in Shiraz and its suburban area were classified into two 
groups: yellow scorpions (Mesobuthus eupeus (n=10), 
Mesobuthus caucasicus (n=9), and Compsobuthus mat-
thiesseni (n=2)) and Hottentotta scorpions (Hottentotta 
jayakari (n=6) and Hottentotta  zagrosensis  (1)) with 
respective prevalence (Fig. 1 to 5). 
During the study period (July 2012 to July 2016), the to-
tal number of scorpion sting cases reviewed was 126. The 
gender distribution showed 59% (n= 74) males and 41% 
(n=52) females. The patients aged 8 to 63 years (mean age 
of 33.8±11.5 years). About 38.4% of the stings occurred 
during summer, most of which occurring in August. More 
than 40% of patients (n=51) referred to the emergency 
department (ED) at night between 00.00 am to 06.00 am. 
The most prevalent site of envenomation was the lower 
extremities (53 cases, 43.1%), followed by upper extremi-
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ties (52 cases, 42.3%), trunk (10 cases, 8.1%), and head 
and neck (9 cases, 7.3%). Also, there was one case of 
simultaneous hand and foot sting and one case of simulta-
neous trunk and hand sting.  
The vast majority of the patients (95; 75.4%) had only 
localized manifestations including local mild to severe 
pain (n=81; 64.3%), burning sensation (n=39; 30.1%), 
mild erythema (n=32; 25.4%), mild swelling (n=12; 
9.5%), pruritus (n=8; 6.3%), and tenderness (n=2; 1.6%). 
The general symptoms included nausea (n=8; 6.3%), ver-
tigo (n=4; 3.2%), fatigue (n=3; 2.4%), dyspnea (n=3; 
2.4%), sweating (n=1; 0.8%), shivering (n=1; 0.8%), chest 
pain (n=1; 0.8%), flushing (n=1; 0.8%), and epigastric 
pain (n=1; 0.8%) with no systemic involvement. Also, 80 
(63.5%) and 15 (11.9%) cases were diagnosed as yellow 
and Hottentotta scorpion stings, respectively. In 31 
(24.6%) of the stung patients, the color of the scorpions 
was not determined.  
The clinical manifestations of scorpion stings with re-
spect to the scorpions’ color and size are given in Table 3. 
Severe localized pain was more prevalent in stings with 
Hottentotta than yellow scorpions (p=0.01, Fisher's exact 
test). In addition, the patients stung with Hottentotta scor-
pions needed more antivenin (p=0.002, Fisher's exact 
test). There were no significant statistical differences be-
tween these two groups regarding other clinical manifesta-
tions, vital signs, clinical severity grading, or length of ED 
stay. 
The classification shown in Table 2 was utilized to 
grade the clinical severity of scorpion envenomation for 
all cases. According to the present clinical severity grad-
ing classification, 65, 43, and 18 of the patients (51.6%, 
34.1%, and 14.3%) were classified in the grades I, II, and 
III, respectively.  
In all cases, the season of envenomation with Hottentot-
ta scorpions was summer, but envenomation with yellow 
scorpions was reported throughout the year. 
The length of ED stay was classified into two groups: 
81 (73 %) patients (of 111 patients with valid data) stayed 
from 1 to 6 hours, and 30 (27%) patients stayed for >6 
hours for observation. Thirty-two patients (25%) dis-
charged themselves against medical advice. 
In general, all patients received intravenous hydrocorti-
sone and intramuscular antihistamines injections. Some of 
the patients received local injection of lidocaine, analge-
sics, meperidine (pethidine), and/or local application of 
ice pack to the sting site for pain relief, and five (4%) pa-
tients received scorpion antivenin. Scorpion antivenin was 
given to the patients with grade III clinical severity grad-
ing classification.  
In 12 cases (2 males and 10 females) of envenomation 
with yellow scorpions, microscopic hematuria was report-
ed in the U/A (positive hemoglobin/blood in urine dipstick 
together with microscopic red blood cells). All patients 
were discharged in good condition. There was no death. 
 
Fig. 2. Mesobuthus caucasicus (original picture) 
 
 
Fig. 3. Compsobuthus matthiesseni (original picture) 
 
 
Fig. 4. Hottentotta jayakari (original picture) 
 
 
Fig. 5. Hottentotta zagrosensis, previously named as Buthotus schach 
(dead specimen; original picture)  
    








Most fatal scorpion envenomations in Iran are related to 
H. lepturus and A. crassicauda species (9-12). This study 
found no envenomation case with these species in Shiraz 
and its suburbs. Azizi et al. in 1998 studied scorpions in 
the villages around Shiraz and reported that M. eupeus, A. 
crassicauda, and H. lepturus fauna were respectively 
more prevalent (95). Moreover, other researchers have 
recently reported M. eupeus, A. crassicauda, and Or-
thochirus scrobiculosus fauna in villages around Shiraz 
(96). The reason for the different fauna reported in these 
two studies and the species of the scorpion samples in the 
current study is unknown, but it might be attributed to the 
reduced population of some species due to the moderniza-
tion of rural areas around Shiraz.   
The clinical manifestations of stings by medically im-
portant scorpions in Iran have been previously reported 
except for H. schach and C. matthiesseni. In addition, the 
systemic clinical manifestations of envenomation by M. 
eupeus and H. saulcyi are questionable. Regarding the 
clinical manifestations of sting by M. eupeus, Radmanesh 
believes that the systemic manifestations of sting by this 
scorpion are caused by the fear of being stung, and this 
species does not cause severe clinical manifestations (9, 
15). However, transient ophthalmoplegia following en-
venomation by M. eupeus has been reported from Iran 
(31). 
The only study reporting the clinical manifestations of 
envenomation with M. eupeus in other countries is a retro-
spective study by Ozkan and Kat on 152 patients in the 
Sanliurfa region of Turkey (97). The most prevalent local 
clinical manifestations of M. eupeus were swelling, hyper-
emia, pain, burning, itching, and numbness, and systemic 
clinical manifestations were reported in 9% of the cases. 
Systemic manifestations consisted of dry mouth, thirst, 
sweating, hypotension, nausea, hypertension, difficulty in 
breathing, tachycardia, an increase of bronchial secretion, 
and cyanosis with respective prevalence. However, la-
boratory identification of the species was not done, and 
the species were identified according to the color of the 
scorpion self-reported by the patients (97). Therefore, 
other species might have been responsible for the so-
called local and systemic manifestations.  
It has been reported that the clinical manifestations of 
envenomation with M. caucasicus is similar to those of M. 
eupeus (9, 72, 73). In the present study, the most common 
general symptoms caused by envenomation with yellow 
scorpions were as follows: nausea (n=8; 6.3%), vertigo 
(n=4; 3.2%), fatigue (n=3; 2.4%), dyspnea (n=3; 2.4%), 
sweating (n=1; 0.8%), shivering (n=1; 0.8%), chest pain 
(n=1; 0.8%), flushing (n=1; 0.8%), and epigastric pain 
(n=1; 0.8%).  
Table 1. Medically important scorpions of Iran and clinical manifestations of their stings (9-12, 14-33) 
Scorpion species Apparent 
color 
Size Clinical manifestations of the sting 
Hemiscorpius lepturus Yellow Male: 5cm 
Female: 
7.5-8cm 
Local: minor to mild local pain, local pruritus, erythema, inflammation, ecchymosis, 
severe swelling, blisters, cellulitis, extensive skin necrosis at the site of the sting. 
Systemic: drowsiness, fatigue, irritability, restlessness, hyperthermia, pallor, sweat-
ing, hypotension, cool extremities, tachycardia, muscle spasms, convulsion. Labora-
tory: leukocytosis, hematuria, hemoglobinuria, myoglobinuria (rhabdomyolysis), 
proteinuria, hemolytic anemia, elevated liver enzymes, increased PT and PTT, DIC, 
HUS, acute renal failure   
Androctonus crassicauda Black 11-12cm Local: local burning pain at the site of the sting. Systemic: due to the increased 
release of acetylcholine and catecholamines: drowsiness, irritability, restlessness, 
decreased level of the consciousness, miosis, tachypnea, excessive sweating, saliva-
tion, diarrhea, nausea, vomiting, urination, severe abdominal cramps, numbness of 
limbs, tachycardia, filiform pulse, hypotension, hypothermia, cool extremities, de-
creased tendon reflexes, cyanosis, excessive thirst, ECG changes, acute pulmonary 
edema, melena, bloody vomiting. Laboratory: leukocytosis, granulocytosis, lym-
phopenia, glucosuria, hemoglobinuria, proteinuria        
Buthotus (Hottentotta)  
saulcyi 
Yellow 12-13 cm Severe pain at the site of the sting, other clinical manifestations (are questionable) 
Odontobuthus doriae Yellow 7-8.5 cm Prolonged severe pain at the site of sting with radiation to its periphery, severe mus-
cle contractions in the affected extremity (twitching), irritability, restlessness, tachy-
cardia, tachypnea, dyspnea, unilateral acute pulmonary edema    
Mesobuthus eupeus Yellow 5-6 cm Local: moderate to severe pain or burning sensation at the site of sting, Systemic: 
thirst, dry mouth, headache, nausea, irritability, restlessness, tachycardia, tachypnea, 
transient ophthalmoplegia 
Orthochirus scrobiculosus Black 2.5-4 cm Severe pain and prolonged itching at the site of sting, one death has been reported 
Apistobuthus pterygocercus Yellow 7-8 cm Anxiety, miosis, rhinorrhea, dacryorrhea, hypersalivation, tachypnea, shortness of 
breath, wheezing, gastric distention, and abdominal bulge 
Mesobuthus (Olivierus) 
caucasicus 
Yellow 6-6.5 cm Similar to the Mesobuthus eupeus 
Hemiscorpius acanthocercus Yellow Male: 5cm 
Female: 
7.5-8cm 
Similar to the Hemiscorpius lepturus, one death has been reported 
Hottentotta zagrosensis 
(previously named as 
Buthotus schach) 
Black 13 cm Not reported 
Compsobuthus matthiesseni Yellow 4-5 cm Hematuria (is questionable) 
DIC: disseminated intravascular coagulation; ECG: electrocardiographic; HUS: hemolytic uremic syndrome; PT: prothrombin time; PTT: partial prothrombin time 
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However, in contrast to Ozkan and Kat’s study (97), the 
vital signs were in the normal limit upon presentation and 
during admission. Most patients had localized manifesta-
tions, and no systemic involvement was found. However, 
in 12 (10%) cases of envenomation with yellow scorpions, 
microscopic hematuria was reported. Menstruation might 
have been responsible for hematuria since 10 patients 
were female, and this was not recorded in the hospital 
records. Moreover, hematuria was reported in even-
omations by C. matthiesseni species (9, 92). 
This is the first report regarding scorpion envenomation 
in adults, form Shiraz and its suburbs, Iran. The only re-
lated study on scorpionism in Shiraz was done by Sagheb 
et al. who had assessed referred patients with scorpion 
envenomation to a tertiary hospital from southern Iran 
(90). They found that 6% of the patients had systemic 
clinical manifestations, among which acute renal failure 
and disseminated intravascular coagulation were the most 
common. H. lepturus was responsible for these two sys-
temic manifestations. The current study is not comparable 
with this study since all referrals including children from 
southern Iran, and other provinces were involved.  
It is for the first time in Iran that envenomations by H. 
jayakari species are reported. Since this species has been 
found in other parts of Iran (11, 83, 94, 98-101), it may be 
listed among the medically important scorpions of Iran. It 
is hunted in Sistan-Baluchestan (83), Hormozgan (94, 
100), and Fars (11) provinces and Qeshm (101), Kish 
(99), Hengam, and Tonb-e Bozorg (98) islands of the Per-
sian Gulf.   
The clinical manifestations of H. zagrosensis sting (pre-
viously named as Buthotus schach) (9, 11, 18, 40, 44, 92, 
93, 102-104) not previously reported from Iran. A per-
centage of stings by Hottentotta scorpions were caused by 
this species. Hottentotta zagrosensis is hunted in Fars, 
Khuzestan, West Azarbaijan (11, 40, 44, 96, 105-107), 
Table 2. Grades of scorpion sting severity on the basis of the reported clinical manifestations of scorpion-stung patients from Iran (9-12, 14-33) 
Grade Clinical picture 
I • Mild localized symptoms  
II • Moderate to severe local pain 
•  or microscopic hematuria 
III • Prolonged severe pain at the site of sting with radiation to its periphery (not responding to treatment), 
• and/or prolonged local severe itching (not responding to treatment), 
• and/or general symptoms  
• or microscopic hemoglobinuria (in endemic regions for H. lepturus or H. acanthocercus)  
IV • Severe cutaneous manifestations (in endemic regions for H. lepturus or H. acanthocercus)  
• and/or abnormal vital signs 
• and/or muscle spasm, twitching  
• and/or dark red urine (gross hemoglobinuria) 
• and/or systemic involvement: cardiovascular and/or respiratory and/or neurological disorders and/or acute renal failure 
• and/or hemolysis, and/or DIC, and/or HUS 
DIC: disseminated intravascular coagulation; HUS: hemolytic uremic syndrome 
 
Table 3. Comparison of clinical manifestations of scorpion stings with respect to the scorpions’ color and size 





Local pain 37 (46.3%) 4 (26.7%) 0.130 
Burning sensation 34 (42.5%) 3 (20%) 0.085 
Mild erythema 26 (32.5%) 4 (26.7%) 0.454 
Severe local pain (with or without radiation to its periphery) 20 (25%) 9 (60%) 0.010 
Mild swelling 10 (12.5%) 2 (13.3%) 0.602 
Local pruritus 6 (7.5%) 1 (6.7%) 0.695 
Local paresthesia 1 (1.3%) 0 (0%) 0.842 
Nausea 5 (6.3%) 0 (0%) 0.415 
Fatigue 2 (2.5%) 1 (6.7%) 0.406 
Dyspnea 1 (1.3%) 0 (0%) 0.842 
Vertigo 2 (2.5%) 1 (6.7%) 0.406 
Sweating 1 (1.3%) 0 (0) 0.842 
Shivering 0 (0%) 1 (6.7%) 0.158 
Chest pain 1 (1.3%) 0 (0%) 0.842 
Flushing 1 (1.3%) 0 (0%) 0.842 
Epigastric pain 1 (1.3%) 0 (0%) 0.842 
Muscle spasm 1 (1.3%) 0 (0%) 0.842 
Pulse rate/min (mean ±SD) 82.50±12.81 86.57±10.88 0.828 
Respiratory rate/min (mean ±SD) 18.06±2.20 17.42±2.06 0.792 
Systolic blood pressure (mmHg) (mean ±SD) 117.01±16.02 127.21±16.42 0.791 
Diastolic blood pressure (mmHg) (mean ±SD) 76.00±14.60 80.42±10.72 0.297 
Microscopic hematuria 9 (11.3%) 0 (0%) 0.197 
Severity grade I 42 (52.5%) 6 (40%) 0.272 
Severity grade II 27 (33.8%) 8 (53.3%) 0.126 
Severity grade III 11 (13.8%) 1 (6.7%) 0.398 
Length of ED stay (˂6h) 51 (71.8%) 9 (60%) 0.270 
Scorpion antivenin administrated  1 (1.3%) 4 (26.7%) 0.002 
SD: standard deviation; ED: emergency department 
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Lorestan (108), Qazvin (109), Chaharmahal-Bakhtiari 
(110, 111), and Kohgiluyeh-Boyer-Ahmad (112) provinc-
es in Iran.  
It was found that scorpion envenomations are more 
common in summer and at night, in line with other studies 
on scorpion envenomation (7, 28, 40-52, 65, 66, 69, 70, 
74-83, 87-89). Moreover, envenomations with Hottentotta 
scorpions were only reported in summer, and the pain was 
more prevalent in patients stung by Hottentotta scorpions 
compared to yellow scorpions. This could be attributed to 
the bigger size of telson of Hottentotta scorpions.  Ac-
cording to the present study, despite the large size, the 
severity of clinical manifestations of Hottentotta species 
envenomation is similar to other studied yellow scorpions, 
except for severe localized pain. 
About 70% of the patients were admitted for 1-6 hours, 
and some insisted on being discharged despite medical 
advice to stay longer, representing their good general con-
dition. Since the severity of most envenomations was 
grade I and II, it seems that scorpion stung patients in Shi-
raz and other geographical regions in Iran, where H. lep-
turus and A. crassicauda stings are not prevalent, can be 
treated in the outpatient departments, not highly crowded 
emergency departments. 
In this study, a grading system for the severity of scor-
pion envenomation was presented for the first time based 
on the clinical manifestations of scorpion stings in Iran. 
This grading could be used for treating patients. So, those 
with grades I and II could be treated symptomatically, and 
scorpion antivenin could be used for patients with grades 
III and VI, similar to the protocol used in managing the 
patients. However, no patient with grade VI severity was 
reported.  
In Iran, Razi Vaccine and Serum Research Institute is 
responsible for producing anti-scorpion serum. This poly-
valent scorpion antivenin is prepared from the purified 
plasma of healthy horses immunized with venoms of the 
six medically important scorpion species in Iran including 
O. doriae, M. eupeus, A. crassicauda, B. saulcyi, B. 
schach, and H. lepturus (113). As previously mentioned, 
H. lepturus and A. crassicauda are among the most dan-
gerous scorpion species in Iran, and their stings can be 
fatal (9-12). Although there is no definite treatment proto-
col for envenomation by these species, Valavi (114) sug-
gests that the best treatment for such stings, in cases pre-
senting no systemic or general symptoms, is slow intrave-
nous administration of one ampule of scorpion antivenin 
after cutaneous testing. Then, the decision to administer 
more antivenin should be made according to repeated 
urine tests (appearance of hemoglobinuria) in cases of H. 
lepturus envenomation and the manifestation of other 
signs and symptoms of A. crassicauda sting. However, in 
patients with hemoglobinuria or systemic or general 
symptoms, 3-6 intravenous antivenins should be slowly 
prescribed after cutaneous testing depending on the severi-
ty of symptoms. If the species of scorpion is not known, 
patients should be treated considering the progression of 
signs and symptoms, appearance of hemoglobinuria, or 
other systemic manifestations (114). 
 In this study, only the adult patients admitted to medi-
cal toxicology center in Shiraz were assessed. Patients 
treated in outpatient departments or not referring to hospi-
tals for treatment due to the mild symptoms were not in-
cluded. In other words, scorpion envenomation is definite-
ly more prevalent in Shiraz compared with the current 
statistics. Also, the results cannot be generalized to chil-
dren since only the adults were included. Furthermore, 
like any other retrospective studies, they were other limi-
tations in our study. Some of the data were missing in 
some of the patients’ chart. Also, some of the charts were 
missing and thus we could not include them in the study. 
 
Conclusion  
It is recommended to list H. jayakari among the medi-
cally important scorpions of Iran. Moreover, it seems that 
patients stung by scorpions in geographical regions in 
which H. lepturus and A. crassicauda stings are not preva-
lent could be treated in outpatient departments. The pre-
sented grading system can be used for treating patients 
with scorpion envenomation. The stung patients with 
grades I and II envenomation could be treated symptomat-
ically, and scorpion antivenin could be used only for pa-
tients with grades III and VI. 
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